Retour

Fractyl Health Presents Clinical Update on Revita® German Real-World Registry for Patients With Advanced Type 2 Diabetes (T2D)

Health Health

FRACTYL HEALTH PRESENTS CLINICAL UPDATE ON REVITA® GERMAN REAL- WORLD REGISTRY FOR PATIENTS WITH ADVANCED TYPE 2 DIABETES (T2D)

GlobeNewswire Inc. • 13/05/2024 à 12:00:00
Fractyl Health, Inc. Common Stock
Address: 3 VAN DE GRAAFF DRIVE
Postal Code: 01803
City: BURLINGTON
State: MA
Phone Number: 781-902-8800
Website: https://www.fractyl.com
Status: Active
Company Info

Fractyl Health Inc is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including type 2 diabetes and obesity. The company focuses on transforming metabolic disease treatment from chronic symptomatic management to durable disease modifying therapies that target the organ level root causes of T2D and obesity.

List Date2024-02-02
MarketStocks
LocalUS
Primary ExchangeXNAS
TypeCS
Currency NameUSD
CIK0001572616
Composite figiBBG002Y7NH72
Share Class figiBBG002Y7NH81
Market Cap295,044,953 USD
SIC Code3841
SIC DescriptionSURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Total Employees94
Share Class Shares Outstanding47900000
Weighted Shares Outstanding47896908
Round Lot100
Updated date2024-06-09
Stats
Last 5 days
10-06
7-06
6-06
5-06
4-06
Last
6.53
6.265
6.626
6.96
6.825
Variance
4.23%
-5.02%
-4.85%
1.77%
1.26%
Open
6.265
6.596
6.964
6.839
6.74
Highest
6.53
6.598
7.005
7.01
6.85
Lowest
6.53
6.58
7.005
7.01
6.85
History
PeriodVarhighestlowest
1 week
-3.12%
6.85
6.53
1 month
4.06%
6.485
6.485
3 month
-23.55%
8.669
6.375
6 month
-52.51%
14.5
6.375
1 year
-52.51%
14.5
6.375
3 year
-52.51%
14.5
6.375
5 year
-52.51%
14.5
6.375
10 year
-52.51%
14.5
6.375
Calendar
11 June 2024 (Time UTC) Actual Previous Consensus
16:30
United States
JUN 07
3034000.000
16:30
United States
JUN 07
483000.000
13:00
United States
4.483
12:00
United States
4.169
11:30
United States
4.895
10:30
United States
08:55
United States
JUN 07
★★
08:30
United States
MAY
3.600
07:55
United States
JUN 07
★★
07:00
United States
★★
07:00
United States
06:00
United States
MAY
89.700
05:00
United States
MAY
10 June 2024 (Time UTC) Actual Previous Consensus
13:00
United States
4.605
11:30
United States
News Stream
Calendar Calendar of Events
Fractyl Health Presents Compelling Preclinical Data from Single-Administration GLP-1 Pancreatic Gene Therapy Rejuva® at Digestive Disease Week 2024
GlobeNewswire Inc. • 3w ago
Stocks Earnings Releases and Operating Results
Fractyl Health Reports First Quarter 2024 Financial Results and Provides Business Updates
GlobeNewswire Inc. • 4w ago
Health Health
FRACTYL HEALTH PRESENTS CLINICAL UPDATE ON REVITA® GERMAN REAL- WORLD REGISTRY FOR PATIENTS WITH ADVANCED TYPE 2 DIABETES (T2D)
GlobeNewswire Inc. • 4w ago
Calendar Calendar of Events
Fractyl Health to Present at BofA Securities 2024 Health Care Conference
GlobeNewswire Inc. • 1mo ago
Calendar Calendar of Events
Fractyl Health to Report First Quarter 2024 Financial Results and Provide Business Updates on May 13, 2024
GlobeNewswire Inc. • 1mo ago
Management Directors and Officers
Fractyl Health Expands Leadership with Appointment of Adrian Kimber as Chief Commercial Officer to Spearhead Anticipated Launch Preparation
GlobeNewswire Inc. • 2mo ago
Stocks Earnings Releases and Operating Results
Fractyl Health Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
GlobeNewswire Inc. • 2mo ago
Health Health
Fractyl Health Receives FDA IDE Approval for the Revita® Remain-1 Pivotal Study of Weight Maintenance in Obesity after Discontinuation of GLP-1 Based Drugs
GlobeNewswire Inc. • 2mo ago
Health Health
Fractyl Health today announced promising new preclinical findings for the first clinical candidate in its Rejuva® pancreatic gene therapy platform.
GlobeNewswire Inc. • 3mo ago
Health Health
Fractyl Health today announced promising new preclinical findings for the first clinical candidate in its Rejuva® pancreatic gene therapy platform.
GlobeNewswire Inc. • 3mo ago
See All

Contactez-nous dès aujourd'hui pour découvrir comment notre solution peut vous aider à tirer parti de la puissance des données.

CONTACTER UN EXPERT